<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35535701</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1365-2060</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>54</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of medicine</Title>
          <ISOAbbreviation>Ann Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effectiveness of gonadotrophin-releasing hormone agonist therapy to improve the outcomes of intrauterine insemination in patients suffering from stage I-II endometriosis.</ArticleTitle>
        <Pagination>
          <StartPage>1330</StartPage>
          <EndPage>1338</EndPage>
          <MedlinePgn>1330-1338</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2022.2071458</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To explore the role of postoperative gonadotrophin releasing hormone agonist (GnRH-a) therapy before treatment with intrauterine insemination (IUI) for infertile females with stage I-II endometriosis.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="UNASSIGNED">Ninety-seven patients diagnosed with stage I-II endometriosis before IUI were enrolled in this study. The clinical pregnancy rate, cumulative pregnancy rate, live birth rate and newborn conditions were compared between the two groups with and without GnRH-a therapy.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The clinical pregnancy rate of IUI in the GnRH-a group was higher than that in the control group (15.29% vs. 11.82%, <i>p</i> = .035). By logistic regression analysis, patients treated with GnRH-a had a higher clinical pregnancy rate than those without (adjusted odds ratio (AOR) 23.190, 95% confidence interval (CI) 1.238-434.312). The live birth rate per IUI cycle in the GnRH-a group was also higher than in the controls (12.94% vs. 10%). However, the difference was not statistically significant (<i>p</i> = .311, AOR 4.844, 95% CI 0.229-102.320). The patients with GnRH-a therapy had a similar incidence of multiple pregnancy rate (0% vs. 0%), miscarriage rate (2.35% vs. 0.91%) and ectopic pregnancy rate (0% vs. 0.91%) as compared to the control group. The cumulative pregnancy rates were all higher in patients administered with GnRH-a than those without GnRH-a treatment in different cycles (one cycle: 17.07% vs 12.50%; two cycles: 29.27% vs 19.64%; three cycles: 31.71% vs 23.21%; ≥four cycles: 31.71% vs 23.21%), but the difference was not statistically significant. Notably, there was no more pregnancy after the third IUI cycle. The gestation weeks of delivery in the two groups were 39.09 ± 1.04 and 38.60 ± 1.17, respectively (<i>p</i> = .323). Nor was there difference in birth weight between the two groups (3236 ± 537 g vs 3435 ± 418 g, <i>p</i> = .360).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The administration of GnRH-a in patients with stage I-II endometriosis could be beneficial to the outcomes of IUI. It is recommended that IUI should be discontinued after three failed attempts. KEY MESSAGESEndometriosis is a common cause of infertility, but the exact mechanism remains unclear.The administration of GnRH-a before IUI treatment is beneficial for patients suffering from stage I-II endometriosis.After three failed attempts, IUI should be stopped in patients with stage I-II endometriosis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Kemei</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Reproductive Medicine Center, Ningbo City First Hospital, Ningbo 315010, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Shisi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Reproductive Medicine Center, Ningbo City First Hospital, Ningbo 315010, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Haiyan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Reproductive Medicine Center, Ningbo City First Hospital, Ningbo 315010, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Jiaou</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Reproductive Medicine Center, Ningbo City First Hospital, Ningbo 315010, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Ensheng</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Reproductive Medicine Center, Ningbo City First Hospital, Ningbo 315010, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Reproductive Medicine Center, Ningbo City First Hospital, Ningbo 315010, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Changling</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Reproductive Medicine Center, Ningbo City First Hospital, Ningbo 315010, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shu</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Reproductive Medicine Center, Ningbo City First Hospital, Ningbo 315010, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ann Med</MedlineTA>
        <NlmUniqueID>8906388</NlmUniqueID>
        <ISSNLinking>0785-3890</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>33515-09-2</RegistryNumber>
          <NameOfSubstance UI="D007987">Gonadotropin-Releasing Hormone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004715" MajorTopicYN="Y">Endometriosis</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007987" MajorTopicYN="Y">Gonadotropin-Releasing Hormone</DescriptorName>
          <QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007314" MajorTopicYN="N">Insemination</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010062" MajorTopicYN="N">Ovulation Induction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018873" MajorTopicYN="N">Pregnancy Rate</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Endometriosis</Keyword>
        <Keyword MajorTopicYN="N">clinical outcome</Keyword>
        <Keyword MajorTopicYN="N">gonadotrophin releasing hormone agonist</Keyword>
        <Keyword MajorTopicYN="N">intrauterine insemination</Keyword>
        <Keyword MajorTopicYN="N">laparoscopy surgery</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>13</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35535701</ArticleId>
        <ArticleId IdType="doi">10.1080/07853890.2022.2071458</ArticleId>
        <ArticleId IdType="pmc">PMC9126587</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Saunders PTK, Horne AW.. 
Endometriosis: etiology, pathobiology, and therapeutic prospects. Cell. 2021;184(11):1330–2824. PMID: 34048704.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7938889</ArticleId>
            <ArticleId IdType="pubmed">33636130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson NP, Hummelshoj L, Adamson GD, et al. . 
World endometriosis society consensus on the classification of endometriosis. Hum Reprod. 2017;32(2):315–324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27920089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gruber TM, Mechsner S.. 
Pathogenesis of endometriosis: the origin of pain and subfertility. Cells. 2021;10(6):1381.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8226491</ArticleId>
            <ArticleId IdType="pubmed">34205040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Missmer SA, Hankinson SE, Spiegelman D, et al. . 
Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol. 2004;160(8):784–796.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15466501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sampson JA.
Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol. 1927;3(2):93–110.43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1931779</ArticleId>
            <ArticleId IdType="pubmed">19969738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez AM, Vanni VS, Bartiromo L, et al. . 
Is the oocyte quality affected by endometriosis? A review of the literature. J Ovarian Res. 2017;10(1):43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5508680</ArticleId>
            <ArticleId IdType="pubmed">28701212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez AM, Pagliardini L, Cermisoni GC, et al. . 
Does endometriosis influence the embryo quality and/or development? Insights from a large retrospective matched cohort study. Diagnostics. 2020;10(2):83.</Citation>
        </Reference>
        <Reference>
          <Citation>Yazdani A.
Surgery or in vitro fertilization: the simplicity of this question belies its complexity. Aust N Z J Obstet Gynaecol. 2017;57(6):676–678.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29210045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson NP.
Review of lipiodol treatment for infertility – an innovative treatment for endometriosis-related infertility?
Aust N Z J Obstet Gynaecol. 2014;54(1):9–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24138402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dumesic DA, Meldrum DR, Katz-Jaffe MG, et al. . 
Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health. Fertil Steril. 2015;103(2):303–316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25497448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin X, Dai Y, Tong X, et al. . 
Excessive oxidative stress in cumulus granulosa cells induced cell senescence contributes to endometriosis-associated infertility. Redox Biol. 2020;30:101431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6974790</ArticleId>
            <ArticleId IdType="pubmed">31972508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor HS, Kotlyar AM, Flores VA.. 
Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397(10276):839–852.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33640070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zondervan KT, Becker CM, Missmer SA.. 
Endometriosis. N Engl J Med. 2020;382(13):1244–1256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32212520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farquhar CM, Liu E, Armstrong S, et al. . 
Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial. Lancet. 2018;391(10119):441–450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29174128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang K, Shi Y, Wang E, et al. . 
Ovarian stimulated cycle: not a better alternative for women without ovulation disorder in intrauterine insemination. Oncotarget. 2017;8(59):100773–100780.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5725063</ArticleId>
            <ArticleId IdType="pubmed">29246021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hodgson RM, Lee HL, Wang R, et al. . 
Interventions for endometriosis-related infertility: a systematic review and network meta-analysis. Fertil Steril. 2020;113(2):374–382.e2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32106991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin KC, Chen HF, Huang PT, et al. . 
Effectiveness of postoperative adjuvant therapy in improving reproductive outcome of endometriosis-associated infertility. J Formos Med Assoc. 2001;100(7):466–470.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11579612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>American Society for Reproductive . Revised American society for reproductive medicine classification of endometriosis: 1996. Fertil Steril. 1997;67:817–821.[Mismatch</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9130884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooper TG, Noonan E, von Eckardstein S, et al. . 
World health organization reference values for human semen characteristics. Hum Reprod Update. 2010;16(3):231–245.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19934213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuznetsov L, Dworzynski K, Davies M, et al. . 
Diagnosis and management of endometriosis: summary of NICE guidance. BMJ. 2017;358:j4227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28893730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunselman GA, Vermeulen N, Becker C, et al. . 
ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–412.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24435778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dückelmann AM, Taube E, Abesadze E, et al. . 
When and how should peritoneal endometriosis be operated on in order to improve fertility rates and symptoms? The experience and outcomes of nearly 100 cases. Arch Gynecol Obstet. 2021;304(1):143–155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8164581</ArticleId>
            <ArticleId IdType="pubmed">33537880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abesadze E, Sehouli J, Mechsner S, et al. . 
Possible role of the posterior compartment peritonectomy, as a part of the complex surgery, regarding recurrence rate, improvement of symptoms and fertility rate in patients with endometriosis, long-term follow-up. J Minim Invasive Gynecol. 2020;27(5):1103–1111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31449906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan Z.
Fertility-related considerations in endometriosis. Abdom Radiol. 2020;45(6):1754–1761.</Citation>
        </Reference>
        <Reference>
          <Citation>Bafort C, Beebeejaun Y, Tomassetti C, et al. . 
Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev. 2020;10(10):CD011031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8428328</ArticleId>
            <ArticleId IdType="pubmed">33095458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson NP, Hummelshoj L.. 
Consensus on current management of endometriosis. Hum Reprod. 2013;28(6):1552–1568.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23528916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bansal P, Khoiwal K, Malhotra N, et al. . 
The role of GnRH analogues in improving outcome in women undergoing superovulation and intrauterine insemination after surgical correction of mild endometriosis: a randomized controlled trial. Eurasian J Med. 2018;50(2):105–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6039146</ArticleId>
            <ArticleId IdType="pubmed">30002577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Depalo R, Jayakrishan K, Garruti G, et al. . 
GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET). Reprod Biol Endocrinol. 2012;10:26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3442989</ArticleId>
            <ArticleId IdType="pubmed">22500852</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song J, Sun X, Qian K.. 
Endometrial but not ovarian response is associated with clinical outcomes and can be improved by prolonged pituitary downregulation in patients with thin and medium endometrium. Reprod Sci. 2019;26(11):1409–1416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30501453</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
